The Department of Veterans Affairs Veterans Health Administration awarded a multiple-award Federal Supply Schedule contract to Biocon Biologics Inc., a foreign-owned, for-profit manufacturer of goods. The contract provides an interim agreement under FSS Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. The potential value of the contract is $25 million. Delivery orders may be placed under the contract through February 2029.
The contract facilitates procurement of pharmaceuticals to support Veterans Health Administration programs. As a multiple-award contract against FSS Schedule 65 I B, it establishes pricing and terms for a range of drugs and medical supplies. Likely items include prescription and over-the-counter medications, as well as products for treating conditions like cancer and blood disorders. No set-asides were specified. Performance will involve delivery of ordered supplies to Veterans Affairs medical centers and clinics nationwide. The award to Biocon Biologics, a manufacturer, indicates an aim to ensure Veterans Affairs' integrated service networks have access to clinically necessary pharmaceuticals.
Generated 1/25/24, 9:07 AM